PREDNISOLONE 5 mg

A wide variety of diseases may sometimes require corticosteroid therapy. Some of the principal indications are:

• bronchial asthma, severe hypersensitivity reactions, anaphylaxis, rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (excluding systemic sclerosis), polyarteritis nodosa;
• inflammatory skin disorders, including pemphigus vulgaris, bullous pemphigoid and pyoderma gangrenosum;
• minimal change nephrotic syndrome, acute interstitial nephritis;
• ulcerative colitis, Crohn's disease; sarcoidosis;
• rheumatic carditis;
• haemolytic anaemia (autoimmune), acute lymphoblastic and chronic lymphocytic leukaemia, malignant lymphoma, multiple myeloma, idiopathic thrombocytopenic purpura;
• immunosuppression in transplantation.

Pharmacotherapeutic group: Glucocorticosteriods

Prednisolone is a glucocorticoid with the general properties of corticosteroids. It is used for its anti-inflammatory and immuno-suppressant properties, which suppress the clinical manifestations of disease in a wide range of disorders.

Please refer to the instructions on the prescription established by your medical doctor.

Adult: 

The dose used will depend upon the disease, its severity, and the clinical response obtained. The following regimens are for guidance only. Divided dosage is usually employed.

• Short-term treatment:
  20 to 30 mg daily for the first few days, subsequently reducing the daily dosage by 2.5 or 5mg every two to five days, depending upon the response.
• Rheumatoid arthritis:
  7.5 to 10mg daily. For maintenance therapy the lowest effective dosage is used.
• Most other conditions:
  10 to 100mg daily for one to three weeks, then reducing to the minimum effective dosage. 

 Method of administration:

The tablets can be swallowed whole, but they are best taken as a drink after dissolving them in a glass of water.
Take your tablets as a single dose each morning, unless your doctor has told you otherwise